Australia is eagerly awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://brontegqex956324.bmswiki.com/6318242/this_new_drug_retatrutide_australia_a_promising_solution_for_losing_weight